Clinical Trial Update: Two Chemotherapy Regimens Plus or Minus Bevacizumab [Phase 2]

View source ↗

Summary

This Phase 2 trial in pancreatic cancer compares two chemotherapy regimens with or without bevacizumab and is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Pancreatic Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING